Aardvark Therapeutics, a clinical‑stage biopharma company focused on hunger suppression, is now the target of a class action lawsuit filed in the Southern District of California. The case alleges that the company misled investors about the safety and prospects of its lead compound, ARD‑101, a gut‑restricted ...
PrymaLab has just done something unusual in the peptide supply world: it opened a free, no‑account, no‑paywall Research Hub for laboratories and researchers. Twelve technical references went live in late August, covering everything from peptide storage and stability to delivery formats and legal status. The move ...
Doctors and dermatologists are warning people to avoid injecting copper peptides, after a growing trend saw the compound move from skincare products into unregulated at-home injections. The main concern is a peptide called GHK-Cu, a copper-bound molecule made of three amino acids. It has been used ...
Scorpion venom may sound dangerous, but scientists are now studying it as a possible source of new treatments for liver disease and inflammation. A recent review published in the journal iLIVER highlights how peptides found in scorpion venom could help target immune responses, fight viruses, and ...
Former UFC interim lightweight champion Dustin Poirier used his recent appearance on The Joe Rogan Experience to spotlight peptides, describing them as recovery tools that could have prolonged his career. Poirier, who retired earlier this year, said he now uses multiple peptides and “feels great,” adding ...
Novo Nordisk has released phase 3 data from the STEP Young trial, marking the first time semaglutide has been tested in children aged 6 to under 12 living with obesity. The results are striking: after 68 weeks of treatment combined with lifestyle modification, 40.4% of children ...
Peptides Canada, a supplier of research‑grade peptide compounds, recently announced continued growth in demand for metabolic research peptides, highlighting retatrutide as a leading compound of interest. The company says Canadian laboratories and research institutions are increasingly sourcing peptides domestically, citing improved catalog availability and reliability compared ...
The chief executive of pharmaceutical company Novo Nordisk has warned that the growing use of unregulated, so-called “black market” peptides promoted online could pose serious health risks, saying people are “gambling” with their bodies by using untested products. Mike Doustdar made the comments in an interview ...
A growing number of people are turning to an experimental anti-ageing compound called copper peptides as an injectable treatment, despite limited evidence on its safety or effectiveness in humans. The substance, known as GHK-Cu, has been widely used for decades in skincare creams and serums and ...
The use of GLP-1 weight-loss medications among children under 12 in the United States remains rare but has increased rapidly in recent years, according to new research. A study led by NYU Langone Health found that prescriptions for drugs such as Saxenda, Wegovy and Zepbound among ...
Health experts are reminding patients that GLP-1 medications, including widely used drugs such as Ozempic, Wegovy, Mounjaro and Zepbound, are most effective when paired with proper nutrition, exercise and lifestyle support. The drugs, originally developed to treat type 2 diabetes, have become popular for weight loss. ...
A large observational study suggests that semaglutide, a widely used GLP-1 diabetes medication, is associated with improved cognitive outcomes in people with psychiatric disorders, particularly in memory and overall mental function. Researchers analysing UK health data found that patients prescribed semaglutide showed better cognitive scores than ...
